Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

US Department of Health and Human Services announced a declaration to provide immunity to legal claims made in the US in relation to three investigational Ebola vaccines.

Legal Immunity Offered to Makers of Ebola Vaccines in the US

On December 8, Pfizer announced that it will establish a research program in gene therapy, and collaborate with Spark Therapeutics in Philadelphia, to develop potential gene therapy treatments for hemophilia.

Pfizer to Intensify AAV Vector Research in Gene Therapy for Hemophilia

Agnes Shanley is senior editor of Pharmaceutical Technology.

Sandoz announces their version of filgrastim, a follow-on biologic for the treatment of neutropenia, is as safe and effective as Amgen's Neupogen.

Sandoz's Biosimilar Shows Similarity to Amgen's Neupogen

The final article of this series will look at the last two steps of the PharmaCare seven-step process?Lubricate and Store.

Seven Steps to Solving Tabletting and Tooling Problems---Step 6: Measure and Step 7: Store

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

No evidence that Fluad vaccine caused deaths in Italy, says EMA.

EMA Reassures Safety of Novartis Flu Vaccine

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Ranbaxy and Epirus announce the launch of India's first biosimilar for Remicade.

First Remicade Biosimilar Hits India

Lung Therapeutics announced that it received Orphan Drug Designation for LTI-01, an injectable designed for the treatment of loculated pleural effusion.

Lung Therapeutics Receives Orphan Drug Designation for Empyema Treatment

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Dual sourcing is one of many possible solutions to securing the supply chain.

Securing the Single-Use Supply Chain

Garrett Krushefski is scientific and technical services manager at SGM Biotech.

Craig A. Wallaceis senior technical specialist at 3M Infection Prevention Division, St. Paul, MN.

Kellie A. Matzinger is manager of Scientific & Technical Services at Mesa Laboratories.

Anthony M. Piotrkowski is regulatory manager at STERIS Corporation in Mentor, OH and co-chair of AAMI ST/WG 04 Biological indicators working group.

In anticipation of this mandatory switch from Oxyfume 2000 to 100% EtO for BI testing, comparison studies were performed to determine if the switch from Oxyfume 2000 to 100% EtO would have any impact on BI resistance label claims.

Effects of 100% Ethylene Oxide Test Gas on the Resistance of Ethylene Oxide Biological Indicators

Matt Bundenthal is direct sales and communications manager at Fette Compacting America, www.fetteamerica.com .

Solving the problem of tablet spots or specks involves prevention and thorough investigation.